Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines.

Clinical and experimental immunology - 1 Apr 2007

Pandha H, Rigg A, John J, Lemoine N

Abstract excerpt

Tumours evade immune recognition and destruction through loss or down-regulation of expression of antigen processing and antigen-presenting molecules such as the human leucocyte antigen (HLA class I) and transporter for antigen presentation (TAP). This study examined the expression of HLA class I, class II and TAP in human pancreatic carcinoma tissue and 19 immortalized pancreatic cancer lines using a panel of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to ATP-Binding Cassette Transporters

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Down-Regulation

Share to Histocompatibility Antigens Class I

Share to Histocompatibility Antigens Class II

Share to Neoplasm Proteins

Share to Pancreatic Neoplasms

Share to Tumor Cells, Cultured

Source

Open in PubMed Open full text

Identifiers

PMID: 17302733
DOI: 10.1111/j.1365-2249.2006.03289.x
PMCID: PMC1868855

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines.PMID 17302733Read ↗

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line.Semantic proximity Read ↗

Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.Semantic proximity Read ↗

Mechanisms of loss of HLA class I expression on colorectal tumor cellsSemantic proximity Read ↗

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancerSemantic proximity Read ↗

Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.Semantic proximity Read ↗

Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.Semantic proximity Read ↗

Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell linesSemantic proximity Read ↗

Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma.Semantic proximity Read ↗

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.Semantic proximity Read ↗

Lack of HLA‐class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expressionSemantic proximity Read ↗

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer.Semantic proximity Read ↗

Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.